Pages that link to "Q28214601"
Jump to navigation
Jump to search
The following pages link to UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells (Q28214601):
Displaying 50 items.
- A Structural basis for the association of DAP12 with mouse, but not human, NKG2D (Q24300593) (← links)
- Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity (Q24303742) (← links)
- Resistance to cytarabine induces the up-regulation of NKG2D ligands and enhances natural killer cell lysis of leukemic cells (Q24654966) (← links)
- (Q28183093) (redirect page) (← links)
- ULBP4 is a novel ligand for human NKG2D (Q28202645) (← links)
- NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation (Q28214524) (← links)
- Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition? (Q28215687) (← links)
- RAET1E2, a soluble isoform of the UL16-binding protein RAET1E produced by tumor cells, inhibits NKG2D-mediated NK cytotoxicity (Q28300038) (← links)
- Genome-wide identification of susceptibility alleles for viral infections through a population genetics approach (Q28748816) (← links)
- Up on the tightrope: natural killer cell activation and inhibition (Q29619175) (← links)
- Regulation of NK cell repertoire and function in the liver (Q30430960) (← links)
- Enhanced prevalence of plasmatic soluble MHC class I chain-related molecule in vascular pregnancy diseases (Q33417775) (← links)
- Two novel human cytomegalovirus NK cell evasion functions target MICA for lysosomal degradation (Q33553680) (← links)
- Synergistic signals for natural cytotoxicity are required to overcome inhibition by c-Cbl ubiquitin ligase (Q33745662) (← links)
- Regulation of human NK-cell cytokine and chemokine production by target cell recognition. (Q33747309) (← links)
- Genomic characterization of remission in juvenile idiopathic arthritis (Q33775236) (← links)
- Transcription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation. (Q33917198) (← links)
- The NKG2D receptor and its ligands-recognition beyond the "missing self"? (Q33964401) (← links)
- NKG2D ligands: unconventional MHC class I‐like molecules exploited by viruses and cancer (Q34197825) (← links)
- Roles of the NKG2D immunoreceptor and its ligands (Q34267094) (← links)
- Genetics, genomics, and evolutionary biology of NKG2D ligands (Q34489980) (← links)
- Recognition of tumors by the innate immune system and natural killer cells (Q34496462) (← links)
- Super-resolution imaging of remodeled synaptic actin reveals different synergies between NK cell receptors and integrins (Q34548289) (← links)
- Expression, signaling proficiency, and stimulatory function of the NKG2D lymphocyte receptor in human cancer cells (Q34652549) (← links)
- NK cells and their ability to modulate T cells during virus infections (Q34700499) (← links)
- NK cell receptors in antiviral immunity (Q34712725) (← links)
- ULBP6/RAET1L is an additional human NKG2D ligand (Q34995891) (← links)
- The innate immune response to tumors and its role in the induction of T-cell immunity (Q35005908) (← links)
- Innate immune recognition by stimulatory immunoreceptors (Q35031959) (← links)
- MHC class I-related chain A and B ligands are differentially expressed in human cervical cancer cell lines (Q35061364) (← links)
- New directions in natural killer cell-based immunotherapy of human cancer (Q35093608) (← links)
- Natural killer cell receptor signaling (Q35145778) (← links)
- Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection (Q35202828) (← links)
- Immune escape and exploitation strategies of cytomegaloviruses: impact on and imitation of the major histocompatibility system (Q35827470) (← links)
- Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors (Q35828771) (← links)
- Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion (Q35848493) (← links)
- Natural killer cells: role in local tumor growth and metastasis (Q35905953) (← links)
- Cytokine modulation of the innate immune system in the treatment of leukemia and lymphoma (Q35909326) (← links)
- Recent developments in the transcriptional regulation of cytolytic effector cells (Q35934180) (← links)
- Cellular immune response to HTLV-1. (Q36254893) (← links)
- Viral strategies for evading antiviral cellular immune responses of the host (Q36276589) (← links)
- Matrine increases NKG2D ligand ULBP2 in K562 cells via inhibiting JAK/STAT3 pathway: a potential mechanism underlying the immunotherapy of matrine in leukemia (Q36309488) (← links)
- NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer (Q36399548) (← links)
- JNK MAP kinase activation is required for MTOC and granule polarization in NKG2D-mediated NK cell cytotoxicity (Q36498465) (← links)
- Commonality of functional annotation: a method for prioritization of candidate genes from genome-wide linkage studies (Q36509138) (← links)
- NK cell receptors as tools in cancer immunotherapy. (Q36543814) (← links)
- Activation and self-tolerance of natural killer cells (Q36652183) (← links)
- Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self (Q36652207) (← links)
- Natural-killer cell ligands at the maternal-fetal interface: UL-16 binding proteins, MHC class-I chain related molecules, HLA-F and CD48. (Q36942362) (← links)
- NK cell receptors and their ligands in leukemia (Q37018656) (← links)